Harbour BioMed Announces Positive Profit Alert
Harbour BioMed announces a positive profit alert for the year ended December 31, 2023.
Uncategorized
OSE Immunotherapeutics Highlights Clinical Portfolio Advancements and Provides 2024 Outlook
OSE Immunotherapeutics SA updates on its clinical portfolio advancements and provides 2024 outlook.
Thermo Fisher Scientific Receives GMP approval from the Italian Medicines Agency (AIFA) for its Manufacturing facility of RNA-Based Products in Monza, Italy
Thermo Fisher Scientific has received Good Manufacturing Practice approval from the Italian Medicines Agency allowing the company to manufacture RNA-based products at its Monza, Italy site.
Dermasensor wins FDA clearance for AI-enabled skin cancer detection device
A study found the sensitivity of the device was 96%, compared with 83% for primary care physicians.
Dermasensor wins FDA clearance for AI-enabled skin cancer detection device Read More »
Patient records exposed in data breaches doubled in 2023
Though the number of data breaches declined slightly from 2022, more than 116 million records were exposed last year, according to a new report from a cybersecurity firm.
Patient records exposed in data breaches doubled in 2023 Read More »
Humana slashes 2023 profit outlook as high medical costs continue
The insurer also lowered its expectations for Medicare Advantage membership growth this year. Humana’s stock dropped 11% in morning trading Thursday to its lowest level since February 2022.
Humana slashes 2023 profit outlook as high medical costs continue Read More »
Bright Health rebrands as NeueHealth, distances itself from insurance portfolio
After exiting the insurance business, the tech company will focus on providing care support and solutions for consumers and providers.
Bright Health rebrands as NeueHealth, distances itself from insurance portfolio Read More »
Apple to sell watches without pulse oximetry after ban of original design takes effect
A court Wednesday denied Apple’s request for an extended stay on an import ban of its smartwatches, after the International Trade Commission found the products infringed Masimo’s patents.
Apple to sell watches without pulse oximetry after ban of original design takes effect Read More »
GAO to review FDA’s oversight of medical device recalls
The government watchdog has accepted a request made in December by Sens. Richard Durbin, D-Ill., and Richard Blumenthal, D-Conn.
GAO to review FDA’s oversight of medical device recalls Read More »
FDA authorizes record number of new devices in 2023
The FDA shared the figures in the CDRH’s annual report, which also features updates on its work on MDUFA V goals.
FDA authorizes record number of new devices in 2023 Read More »